IMPORTANT SAFETY INFORMATION
Aggrenox® (aspirin/extended-release dipyridamole) 25
mg/200 mg capsules is a prescription medicine used to lower the risk
of stroke in people who have had a "mini-stroke" (transient ischemic
attack or TIA) or stroke due to a blood clot.
AGGRENOX should be avoided in patients who are allergic to any
ingredient in AGGRENOX, or allergic to non-steroidal anti-inflammatory
drugs (NSAIDs), or who have the combination of asthma, runny nose, and
nasal polyps. AGGRENOX should not be given to a child or teenager.
AGGRENOX increases the risk of bleeding, including bleeding into
the brain, stomach or intestines. Any bleeding you have may take
longer to stop when you are taking AGGRENOX.
AGGRENOX should be avoided by patients with a history of stomach
ulcers or those who drink three or more alcoholic drinks a day, as
these can increase the risk of bleeding. Patients should tell their
doctor about all medicines they are taking, especially blood thinners,
heparin, warfarin, NSAIDs, heart medicines, or medicines for high
blood pressure, including diuretics ("water pills").
AGGRENOX should be avoided during pregnancy, especially in the
third trimester. AGGRENOX should be avoided in patients with severe
liver or kidney problems. The most common side effects of AGGRENOX are
headache, upset stomach, and diarrhea.
You are encouraged to report negative side effects of prescription
drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Click here for full Prescribing Information including Patient Information.
Please see the Important Safety Information above as well as the full Prescribing Information including Patient Information at www.aggrenox.com.